Type 2 Diabetes Connect
  • Saved

1yr
Relationship Between Diabetes Mellitus and Periodontal/Peri-Implant Disease: A Contemporaneous Review - PubMed

Relationship Between Diabetes Mellitus and Periodontal/Peri-Implant Disease: A Contemporaneous Review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38614881/

The prevalence of diabetes mellitus (DM), a major chronic disease and a leading cause of death and disability around the world, is rising. According to the latest data, the global...

The review highlights the bidirectional relationship between diabetes mellitus and periodontal/peri-implant disease, emphasizing the importance of glycaemic control and oral hygiene in preventing and managing these conditions.

  • Saved

1yr
Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial - PubMed

Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/37922013/

This study was supported by a grant from the Dutch Diabetes Research Foundation (2017-81-014).

This study found that oral magnesium supplementation in individuals with insulin-treated type 2 diabetes and low magnesium levels did not improve insulin sensitivity or glucose control, despite increasing serum magnesium levels.

  • Saved

1yr
Innovative Cardiovascular Research Insights at AHA’s 100th Anniversary

At the American Heart Association’s centennial conference, Dr. Amit Khera, Director of Preventive Cardiology and Professor at UT Southwestern Medical Center, and Dr. John L. Sapp, Assistant Dean of Clinical Research at Dalhousie University, presented key findings. Topics included Tirzepatide’s impact on HFpEF and obesity, the comparison of left atrial appendage closure versus anticoagulation for atrial fibrillation, intensive blood pressure control in diabetes, and insights from the VANISH2 trial on ventricular tachycardia. These findings provide healthcare professionals with evidence-based strategies to advance cardiovascular care.

  • Saved

1yr
A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer's disease, and their co-morbidities - PubMed

A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer's disease, and their co-morbidities - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38379904/

The global prevalence of type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD) is rapidly increasing, revealing a strong association between these two diseases. Currently, there are no curative medication...

This paper explores the role of ceramide metabolism in the pathogenesis of type 2 diabetes mellitus and Alzheimer's disease, highlighting its potential as a therapeutic target for their comorbidity treatment.

  • Saved

1yr
Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists - PubMed

Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38275636/

Type 2 diabetes mellitus (T2DM) is a prevalent and complex metabolic disorder associated with various complications, including cardiovascular diseases. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists...

This review explores the cardiovascular benefits of SGLT2 inhibitors and GLP1 receptor agonists in Type 2 diabetes, highlighting their mechanisms and emerging evidence for improving heart health beyond glucose control.